Lewis Lorraine, Cox Jennifer, Morgia Marita, Atyeo John, Lamoury Gillian
Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital Sydney, New South Wales, Australia.
Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital Sydney, New South Wales, Australia ; Faculty of Health Sciences, University of Sydney Sydney, New South Wales, Australia.
J Med Radiat Sci. 2015 Sep;62(3):177-83. doi: 10.1002/jmrs.114. Epub 2015 Jun 23.
The clinical target volume (CTV) for early stage breast cancer is difficult to clearly identify on planning computed tomography (CT) scans. Surgical clips inserted around the tumour bed should help to identify the CTV, particularly if the seroma has been reabsorbed, and enable tracking of CTV changes over time.
A surgical clip-based CTV delineation protocol was introduced. CTV visibility and its post-operative shrinkage pattern were assessed. The subjects were 27 early stage breast cancer patients receiving post-operative radiotherapy alone and 15 receiving post-operative chemotherapy followed by radiotherapy. The radiotherapy alone (RT/alone) group received a CT scan at median 25 days post-operatively (CT1rt) and another at 40 Gy, median 68 days (CT2rt). The chemotherapy/RT group (chemo/RT) received a CT scan at median 18 days post-operatively (CT1ch), a planning CT scan at median 126 days (CT2ch), and another at 40 Gy (CT3ch).
There was no significant difference (P = 0.08) between the initial mean CTV for each cohort. The RT/alone cohort showed significant CTV volume reduction of 38.4% (P = 0.01) at 40 Gy. The Chemo/RT cohort had significantly reduced volumes between CT1ch: median 54 cm(3) (4-118) and CT2ch: median 16 cm(3), (2-99), (P = 0.01), but no significant volume reduction thereafter.
Surgical clips enable localisation of the post-surgical seroma for radiotherapy targeting. Most seroma shrinkage occurs early, enabling CT treatment planning to take place at 7 weeks, which is within the 9 weeks recommended to limit disease recurrence.
早期乳腺癌的临床靶区(CTV)在计划计算机断层扫描(CT)上难以清晰识别。插入肿瘤床周围的手术夹应有助于识别CTV,尤其是在血清肿已被吸收的情况下,并能追踪CTV随时间的变化。
引入了基于手术夹的CTV勾画方案。评估了CTV的可视性及其术后缩小模式。研究对象为27例仅接受术后放疗的早期乳腺癌患者和15例接受术后化疗后再放疗的患者。单纯放疗(RT/alone)组在术后中位25天(CT1rt)进行一次CT扫描,在40 Gy时,中位68天(CT2rt)进行另一次扫描。化疗/放疗组(chemo/RT)在术后中位18天(CT1ch)进行一次CT扫描,在中位126天(CT2ch)进行一次计划CT扫描,在40 Gy时(CT3ch)进行另一次扫描。
各队列的初始平均CTV之间无显著差异(P = 0.08)。单纯放疗队列在40 Gy时CTV体积显著减少38.4%(P = 0.01)。化疗/放疗队列在CT1ch(中位54 cm³(4 - 118))和CT2ch(中位16 cm³,(2 - 99))之间体积显著减小(P = 0.01),但此后体积无显著减小。
手术夹可实现术后血清肿的定位,用于放疗靶向。大多数血清肿在早期缩小,使得CT治疗计划能够在7周时进行,这在推荐的9周内,以限制疾病复发。